Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
---|---|---|---|---|---|---|---|---|
2024-11-19 | Humacyte, Inc. | Niklason Laura E
(President, CEO and Director) |
P | Common Stock | A | 1797 | $4.44 - $4.44 | $7,978 |
2024-11-19 | Humacyte, Inc. | Dougan Brady W
(Director) |
P | Common Stock | A | 1797 | $4.44 - $4.44 | $7,978 |
2024-11-18 | Humacyte, Inc. | Niklason Laura E
(President, CEO and Director) |
S | Common Stock | D | 1500000 | $4.34 - $4.44 | $6,606,798 |
2024-11-18 | Humacyte, Inc. | Dougan Brady W
(Director) |
S | Common Stock | D | 1500000 | $4.34 - $4.44 | $6,606,798 |
2024-09-13 | Humacyte, Inc. | Green Charles Bruce
(Director) |
M | Common Stock | A | 1200 | $4.09 - $4.09 | $4,908 |
2024-09-10 | Humacyte, Inc. | Sebelius Kathleen
(Director) |
S | Common Stock | D | 5182 | $5.39 - $5.41 | $28,002 |
2024-09-10 | Humacyte, Inc. | Sebelius Kathleen
(Director) |
M | Common Stock | A | 7000 | $3.35 - $4.34 | $27,925 |
2024-09-09 | Humacyte, Inc. | Dougan Brady W
(Director) |
S | Common Stock | D | 446378 | $5.23 - $5.42 | $2,364,520 |
2024-09-09 | Humacyte, Inc. | Niklason Laura E
(President, CEO and Director) |
S | Common Stock | D | 446378 | $5.23 - $5.42 | $2,364,520 |
2024-08-27 | Humacyte, Inc. | Dougan Brady W
(Director) |
S | Common Stock | D | 881878 | $6.35 - $6.71 | $5,724,138 |
2024-08-27 | Humacyte, Inc. | Niklason Laura E
(President, CEO and Director) |
S | Common Stock | D | 881878 | $6.35 - $6.71 | $5,724,138 |
2024-08-27 | Humacyte, Inc. | Sander Dale A.
(CFO and Chief Corp. Deve. Off.) |
S | Common Stock | D | 39389 | $6.68 - $6.68 | $263,118 |
2024-08-27 | Humacyte, Inc. | Sander Dale A.
(CFO and Chief Corp. Deve. Off.) |
M | Common Stock | A | 39389 | $2.56 - $2.56 | $100,835 |
2024-08-15 | Humacyte, Inc. | Constantino Micha...
(Director) |
P | Common Stock | A | 3100 | $6.29 - $6.29 | $19,493 |
2024-06-14 | Humacyte, Inc. | Sebelius Kathleen
(Director) |
M | Common Stock | A | 39389 | $2.56 - $2.56 | $100,835 |
2024-06-11 | Humacyte, Inc. | Niklason Laura E
(President, CEO and Director) |
S | Common Stock | D | 630148 | $7.02 - $7.30 | $4,520,023 |
2024-06-11 | Humacyte, Inc. | Dougan Brady W
(Director) |
S | Common Stock | D | 630148 | $7.02 - $7.30 | $4,520,023 |
2024-06-04 | Humacyte, Inc. | Niklason Laura E
(President, CEO and Director) |
P | Common Stock | A | 2362 | $6.35 - $6.35 | $14,998 |
2024-06-04 | Humacyte, Inc. | Dougan Brady W
(Director) |
P | Common Stock | A | 2362 | $6.35 - $6.35 | $14,998 |
2024-05-31 | Humacyte, Inc. | Niklason Laura E
(President, CEO and Director) |
S | Common Stock | D | 1001852 | $7.28 - $8.93 | $7,832,198 |
2024-05-31 | Humacyte, Inc. | Dougan Brady W
(Director) |
S | Common Stock | D | 1001852 | $7.28 - $8.93 | $7,832,198 |
2024-06-03 | Humacyte, Inc. | Dougan Brady W
(Director) |
P | Common Stock | A | 2050 | $7.37 - $7.37 | $15,108 |
A | Grant, award or other acquisition |
C | Conversion of Derivative or Security |
D | Disposition to the issuer of issuer equity securities |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability |
G | Bona fide Gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary Transaction |
J | Other acquisition or disposition |
K | Transaction in equity swap or instrument with similar characteristics |
L | Small Acquisition |
M | Exercise or conversion of derivative security |
O | Exercise of out-of-the-money derivative security |
P | Open Market Purchase |
S | Open Market Sale |
U | Disposition pursuant to a tender of shares in a change of control transaction |
V | Transaction Voluntarily Reported |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |